Photo of Mr Vikram Talaulikar

Mr Vikram Talaulikar

Telephone:

Email:

Location:

  • University College Hospital

GMC/GDC number:

7031229

Professional background

Mr. Vikram Talaulikar is an associate specialist at the reproductive medicine unit in University College London Hospitals NHS Foundation Trust and hon. associate professor at University College London.

He graduated in medicine in India in 2003 and completed postgraduate degree in obstetrics and gynaecology in 2007.

He was awarded FRCOG in 2022 and completed PhD degree at St. George's University of London in 2016.

He cares for women and couples who have difficulty conceiving, and his clinical interests include reproductive endocrinology, premature ovarian failure, polycystic ovary syndrome, recurrent miscarriage, menopause and male factor subfertility.

He is a certified ‘menopause specialist’ by the British Menopause Society. He has published widely in the area of reproductive medicine. His research focuses around events at the embryo-maternal interface in early pregnancy, ovarian response to stimulation in various endocrine conditions and menopause. 

He is a member of the British Fertility Society, International Menopause Society and European Society of Human Reproduction and Embryology.

Specialties

Research interests

  • Reproductive endocrinology
  • Subfertility
  • Polycystic ovary syndrome
  • Recurrent miscarriage
  • Premature ovarian failure
  • Menopause
  • Trophoblast-decidua interactions

Languages spoken

Hindi, Konkani, Marathi

Publications

Cameron-Pimblett A, Davies MC, Burt E, Talaulikar VS, La Rosa C, King TFJ, Conway GS. Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2820-26.

Cardona Attard C, Cameron-Pimblett A, Puri D, Elliot J, Wilson JC, Talaulikar VS, Davies MC, Conway GS. Fracture rate in women with oestrogen deficiency - Comparison of Turner syndrome and premature ovarian insufficiency. Clin Endocrinol (Oxf). 2019 Dec;91(6):743-9.

Burt E, Davies MC, Yasmin E, Cameron-Pimblett A, Mavrelos D, Talaulikar V, Conway GS. Reduced uterine volume after induction of puberty in women with hypogonadism. Clin Endocrinol (Oxf). 2019 Dec;91(6):798-804.

Talaulikar VS, Conway GS, Pimblett A, Davies MC. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Fertil Steril. 2019 Mar;111(3):505-9.

Talaulikar VS, Bajoria R, Ehidiamhen AJ, Mujawar E, Chatterjee R. A 10-year longitudinal study of evaluation of ovarian reserve in women with transfusion-dependent beta thalassaemia major. Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:38-43.

Talaulikar V, Yasmin E. WHO type 1 anovulation: an update on diagnosis, management and implications for long?term health. The Obstetrician and Gynaecologist. First published: 26 March 2020 https://doi.org/10.1111/tog.12665.

Vikram Talaulikar. See your GP about the menopause. The Menopause Exchange, Issue 82, Page 4, Autumn 2019.

Isaac Manyonda, Vikram S Talaulikar, Roxanna Pirhadi, Joseph Onwude. Progestogens are the problem in hormone replacement therapy: Time to reappraise their use. Post Reproductive Health. 2019 Volume: 26 issue: 1, page(s): 26-31.

Vikram Talaulikar, Sabaratnam Arulkumaran. Folic Acid and Reproductive Health. J Jaffna Sci.Association,2019, 1(1),1-11.

Talaulikar V. HRT Myths in Menopause Exchange Autumn issue, November 2018.

Sauer U, Talaulikar V, Davies MC. Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase. Maturitas 2018; https://doi.org/10.1016/j.maturitas.2018.07.016.

Mushi Matjila and Vikram Talaulikar. Miscarriage and recurrent miscarriage, Chapter 38 in Oxford Textbook of Obstetrics and Gynaecology, Edited by Sabaratnam Arulkumaran, William Ledger, Lynette Denny, and Stergios Doumouchtsis. Pages 477-88. Oxford University Press. Published: 23 January 2020.

Mavrelos D, Al Chami A, Talaulikar V, Burt E, Webber L, Ploubidis G, Yasmin E. Variation in antral follicle counts at different times in the menstrual cycle: does it matter? Reproductive BioMedicine Online, 2016; Reproductive Healthcare Ltd. Published by Elsevier Ltd., http://dx.doi.org/10.1016/j.rbmo.2016.04.012.

Wilson A, Brandon R, Cavell D, Murphy E, Stewart F, Thomas S, Talaulikar V and Wilcox G. The experiences and information requirements of women with a mucopolysaccharide (MPS) or related condition during pregnancy, birth and the postnatal period. Abstracts / Molecular Genetics and Metabolism 2016;117:S14–S124.

Talaulikar VS, Hussain S, Perera A, Manyonda IT. Low participation rates amongst Asian women: implications for research in reproductive medicine, European Journal of Obstetrics & Gynecology and Reproductive Biology (2013), http://dx.doi.org/10.1016/j.ejogrb.2013.11.026.

Sinai Talaulikar V, Kronenberger K, Bax BE, Moss R and Manyonda I. Differences in collagen ultrastructure of human first trimester decidua basalis and parietalis: Implications for trophoblastic invasion of the placental bed. J. Obstet. Gynaecol. Res. 2014; 40, 1:80–8.

Gupta S, Talaulikar VS, Onwude J, Manyonda I. A pilot study of Foley's catheter balloon for prevention of intrauterine adhesions following breach of uterine cavity in complex myoma surgery. Arch Gynecol Obstet. 2013 Apr 12.

Talaulikar VS, Bax BE, Page NM, Manyonda I. A novel hysteroscopic technique for the accurate biopsy of deciduas parietalis and basalis. Placenta 2012; 33: 473-79.

Talaulikar VS, Chambers T, Manyonda I.Exploiting the antioxidant potential of a common vitamin: Could vitamin C prevent postmenopausal osteoporosis? J Obstet Gynaecol Res 2012; 38(1):253-7.

Talaulikar V. Vitamin C and E to prevent preeclampsia in diabetic women. The Lancet 2010; 376 (9753): 1642-43.Sinai Talaulikar V, Chatterjee R, Bajoria R. Reversal of hypogonadotropic hypogonadism with spontaneous pregnancy in betathalassaemia major with transfusional haemosiderosis, Eur J Obstet Gynecol (2017), http://dx.doi.org/10.1016/j.ejogrb.2017.08.012.

Talaulikar VS, Gupta S, Manyonda I. Pregnancy after complex myomectomy: neither age of patient nor size, number or location of fibroids should be a barrier. J R Soc Med Sh Rep 2012; 3:19Talaulikar V, Saridogan E. Medical treatment of uterine fibroids. Hospital Pharmacy Europe, Issue 85 Spring 2017.

Sinai Talaulikar V, Tang T, Yasmin E. Role of Metformin in Women’s Health: Review of Its Current Place in Clinical Practice and Emerging Indications for Future. Obstetrical and Gynecological Survey 2016;71,5:307-17.

Sinai Talaulikar V. Menopause and hormone replacement therapy. Glob. libr. women’s med., April 2015; GLOWM.Sinai Talaulikar V, Manyonda I. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids. Womens Health (2014) 10(6), 565–570. Future Medicine Ltd.

Sinai Talaulikar V, Arulkumaran S. Uterus sparing surgical or radiological treatment of major postpartum haemorrhage: efficacy and implications for future fertility. Glob. libr. women’s med., February 2014; GLOWM.

Talaulikar VS, Arulkumaran S. Maternal, perinatal and long-term outcomes after assisted reproductive techniques (ART): implications for clinical practice. Eur J Obstet Gynecol Reprod Biol. 2013 Aug;170(1):13-9.Talaulikar VS, Belli A, Manyonda I. GnRH Agonists: Do They Have a Place in the Modern Management of Fibroid Disease? The Journal of Obstetrics and Gynecology of India 2012, 62; 5: 506-10.